西方国家医疗领域新自由主义改革的后果及启示──基于试错能力的分析  

The Consequences and Enlightenment of Neoliberalism Reform in Medical Field in Western Countries:Analysis Based on Trial and Error Ability

作　　者：徐振伟[1] XU Zhenwei

机构地区：[1]南开大学周恩来政府管理学院,300350

出　　处：《国外社会科学前沿》2024年第3期28-41,共14页JOURNAL OF INTERNATIONAL SOCIAL SCIENCES

摘　　要：20世纪80年代西方国家的新自由主义改革是一次试错的过程,医疗领域的新自由主义改革即私有化、市场化、自由化使得试错权掌握在垄断资本和少数政治精英的手中,导致试错的成本不断增加。在新冠疫情爆发后,西方国家开始了新的试错,但基于历史惯性和制度设计等路径依赖的影响,西方国家在医疗领域的试错权仍被少数精英掌控,其应对疫情的试错能力被大大削弱。基于此,中国应该吸取西方国家的经验教训,充分发挥社会主义制度的优越性,避免医疗领域改革的试错权为少数精英所垄断,从而提高公共卫生治理的试错能力。The neoliberalism reform in Western countries in the 1980s was a trial and error process.The neoliberalism reform in the medical field,namely privatization,marketization,and liberalization,made the right of trial and error in the hands of monopoly capital and political elites,leading to increasing costs of trial and error.After the outbreak of COVID-19 epidemic,Western countries began a new trial and error process,but based on the influence of historical inertia and institutional design and other path dependence,the right of trial and error of Western countries in the medical field is still controlled by a small number of elites,and their trial and error ability of responding to the epidemic is greatly weakened.Based on this,China should learn from the experience and lessons of Western countries,make full use of superiority of socialism system,and avoid the monopoly of trial and error right in medical reform by a small number of elites,so as to enhance trial and error ability of public health governance.

关 键 词：试错能力 试错权 新自由主义 医疗改革 

分 类 号：D035[政治法律—政治学] R19[医药卫生—卫生事业管理]